Applied Dna Scns (APDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
Sales | 841 | 637 | 597 | 729 | 645 |
Gross Profit | 841 | 637 | 597 | 729 | 645 |
Operating Expenses | 3,328 | 3,764 | 4,410 | 3,081 | 3,488 |
Operating Income | -2,487 | -3,127 | -3,813 | -2,352 | -2,843 |
Interest Expense | 0 | 0 | 0 | 2 | 0 |
Other Income | 568 | 377 | -2,479 | -1,364 | 707 |
Pre-tax Income | -1,919 | -2,750 | -6,292 | -3,719 | -2,136 |
Net Income Continuous | -1,919 | -2,750 | -6,292 | -3,719 | -2,136 |
Net Income | $-1,919 | $-2,750 | $-6,292 | $-3,719 | $-2,136 |
EPS Basic Total Ops | -112.00 | -160.00 | -384.00 | -728.96 | 0.00 |
EPS Basic Continuous Ops | -113.14 | -163.34 | -382.33 | -202.47 | -141.86 |
EPS Diluted Total Ops | -112.00 | -160.00 | -384.00 | -728.96 | 0.00 |
EPS Diluted Continuous Ops | -113.14 | -163.34 | -382.33 | -202.47 | -141.86 |
EBITDA(a) | $-2,374 | $-3,020 | $-3,708 | $-2,251 | $-2,781 |